AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $691,911 | -89.9% | 9,900 | -89.6% | 0.00% | -91.7% |
| Q2 2023 | $6,868,379 | +340.8% | 95,580 | +373.2% | 0.02% | -14.3% |
| Q4 2022 | $1,558,026 | +535.9% | 20,200 | +267.3% | 0.03% | +460.0% |
| Q3 2022 | $245,000 | -28.6% | 5,500 | -33.7% | 0.01% | -44.4% |
| Q1 2022 | $343,000 | -98.1% | 8,295 | -95.1% | 0.01% | -99.2% |
| Q4 2019 | $17,599,000 | +28285.5% | 170,268 | +854.5% | 1.14% | +3837.9% |
| Q3 2018 | $62,000 | – | 17,838 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |